In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing ...

The secret to the success of the program was an anonymous cancer patient who fully consented to making the genetic code of ...

For a few individuals, scientists found genetic material from cancerous tumors in blood samples taken years before they were ...

An international team of scientists has decoded some of the most stubborn, overlooked regions of the human genome using ...

Explore the current and future potential of the whole genome sequencing (WGS) market in this comprehensive report. With projections through 2030, it covers market estimates by product type, ...

The University of Minnesota is known for making great strides in research. Dr. Branden Moriarity joins Susan-Elizabeth Littlefield on WCCO Sunday Morning at 7 a.m. to share a big announcement.

The utility of this browser is not limited to cancer-related data. As genome-wide high-throughput data become more available, we expect such tools to be increasingly important in disease research.

Precision cancer treatment on a larger scale is moving closer after researchers have developed an AI platform that can tailor protein components and arm the patient's immune cells to fight cancer.

An ASCO provisional clinical opinion offers timely clinical direction to ASCO's membership following publication or presentation of potentially practice-changing data from major studies. This ...

Through its Executive Health Program and 100+ Longevity Programs, Human Longevity has delivered care to over 10,000 members using a comprehensive platform that integrates whole genome sequencing ...

Genome-wide association studies have identified several single-nucleotide polymorphisms (SNPs) linked to colorectal cancer (CRC) risk in European and Asian populations, but studies in admixed ...

Brenda Denzler is a writer and editor living in North Carolina. She was diagnosed with inflammatory breast cancer in 2009. Catch up on Brenda’s blogs here. Dear Brenda, You’ve just been diagnosed with ...